Drug
Sodium Fluoride
Sodium Fluoride: highest development phase Phase 2, developed by GlaxoSmithKline. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- GlaxoSmithKline
Trials
| Drug | Phase | Indication |
|---|---|---|
| Sodium fluoride NCT01128972 | Phase 2 | Tooth Erosion |
| Sodium Fluoride NCT01657903 | Not Applicable | Dental Erosion |
Latest
No recent events.
Follow Sodium Fluoride on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.